266 related articles for article (PubMed ID: 26052913)
1. Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.
Peffault de Latour R; Peters C; Gibson B; Strahm B; Lankester A; de Heredia CD; Longoni D; Fioredda F; Locatelli F; Yaniv I; Wachowiak J; Donadieu J; Lawitschka A; Bierings M; Wlodarski M; Corbacioglu S; Bonanomi S; Samarasinghe S; Leblanc T; Dufour C; Dalle JH; ;
Bone Marrow Transplant; 2015 Sep; 50(9):1168-72. PubMed ID: 26052913
[TBL] [Abstract][Full Text] [Related]
2. Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.
Li Q; Luo C; Luo C; Wang J; Li B; Ding L; Chen J
Ann Hematol; 2017 Aug; 96(8):1389-1397. PubMed ID: 28623394
[TBL] [Abstract][Full Text] [Related]
3. [Molecular diagnosis and hematopoietic stem cell transplantation in 17 children with inherited bone marrow failure syndrome].
Li Q; Li B; Luo C; Wang J; Luo C; Ding L; Chen J
Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):817-23. PubMed ID: 26758319
[TBL] [Abstract][Full Text] [Related]
4. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation.
Dietz AC; Mehta PA; Vlachos A; Savage SA; Bresters D; Tolar J; Boulad F; Dalle JH; Bonfim C; de la Fuente J; Duncan CN; Baker KS; Pulsipher MA; Lipton JM; Wagner JE; Alter BP
Biol Blood Marrow Transplant; 2017 May; 23(5):726-735. PubMed ID: 28115275
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell transplantation for classical inherited bone marrow failure syndromes: an update.
Pierri F; Faraci M; Giardino S; Dufour C
Expert Rev Hematol; 2021 Oct; 14(10):911-925. PubMed ID: 34488529
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2008-2009: report on behalf of the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group.
Mohamed SY; Fadhil I; Hamladji RM; Hamidieh AA; Fahmy O; Ladeb S; Alimoghaddam K; Elhaddad A; Nacer RA; Alsharif F; Rasheed W; Jahani M; Mousavi SA; Alseraihy A; Abdel-Rahman F; Al Jefri A; Hussein AA; Alabdulaaly A; Ibrahim A; Bekadja MA; Abboud M; Ahmed P; Dennison D; Bakr M; Benchekroun S; Hussain F; Othman TB; Aljurf M; Ghavamzadeh A
Hematol Oncol Stem Cell Ther; 2011; 4(2):81-93. PubMed ID: 21727769
[TBL] [Abstract][Full Text] [Related]
7. Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT.
Dietz AC; Savage SA; Vlachos A; Mehta PA; Bresters D; Tolar J; Bonfim C; Dalle JH; de la Fuente J; Skinner R; Boulad F; Duncan CN; Baker KS; Pulsipher MA; Lipton JM; Wagner JE; Alter BP
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1422-1428. PubMed ID: 28533057
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic cell transplantation for nonmalignant disorders.
Tolar J; Mehta PA; Walters MC
Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S166-71. PubMed ID: 22226101
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplantation for inherited bone marrow failure syndromes: alternative donor and disease-specific conditioning regimen with unmanipulated grafts.
Lu Y; Xiong M; Sun RJ; Zhao YL; Zhang JP; Cao XY; Liu DY; Wei ZJ; Zhou JR; Lu DP
Hematology; 2021 Dec; 26(1):134-143. PubMed ID: 33491597
[No Abstract] [Full Text] [Related]
10. [Change in paradigm in the treatment of pediatric acquired bone marrow failure syndromes in Hungary].
Kállay K; Csomor J; Ádám E; Bödör C; Kassa C; Simon R; Kovács G; Péter G; Ottóffy G; Bartyik K; Kiss C; Masát P; Réti M; Tóth B; Kriván G
Orv Hetil; 2018 Oct; 159(42):1710-1719. PubMed ID: 30334483
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.
Dalle JH; Peffault de Latour R
Int J Hematol; 2016 Apr; 103(4):373-9. PubMed ID: 26872907
[TBL] [Abstract][Full Text] [Related]
12. Minimal intensity conditioning strategies for bone marrow failure: is it time for "preventative" transplants?
Agarwal S
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):135-140. PubMed ID: 38066900
[TBL] [Abstract][Full Text] [Related]
13. Incident cancers and late mortality in Australian children treated by allogeneic stem cell transplantation for non-malignant diseases.
Nelson AS; Vajdic CM; Ashton LJ; Le Marsney RE; Nivison-Smith I; Wilcox L; Dodds AJ; O'Brien TA;
Pediatr Blood Cancer; 2017 Jan; 64(1):197-202. PubMed ID: 27671369
[TBL] [Abstract][Full Text] [Related]
14. Optimizing diagnostic methods and stem cell transplantation outcomes in pediatric bone marrow failure: a 50-year single center experience.
Vissers L; van der Burg M; Lankester A; Smiers F; Mohseny A
Eur J Pediatr; 2023 Sep; 182(9):4195-4203. PubMed ID: 37439851
[TBL] [Abstract][Full Text] [Related]
15. Reduced-intensity conditioning (RIC) in children with nonmalignant disorders (NMD) undergoing unrelated donor umbilical cord blood transplantation (UCBT).
Parikh S; Szabolcs P
Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S53-5. PubMed ID: 22226113
[No Abstract] [Full Text] [Related]
16. Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.
Marotta S; Pagliuca S; Risitano AM
Expert Rev Hematol; 2014 Dec; 7(6):775-89. PubMed ID: 25331515
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Outcomes of Cord Blood Transplantation from an HLA-Identical Sibling for Patients with Bone Marrow Failure Syndromes: A Report From Eurocord, Cord Blood Committee and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation.
Pagliuca S; Peffault de Latour R; Volt F; Locatelli F; Zecca M; Dalle JH; Comoli P; Vettenranta K; Diaz MA; Reuven O; Bertrand Y; Diaz de Heredia C; Nagler A; Ghavamzadeh A; Sufliarska S; Lawson S; Kenzey C; Rocha V; Dufour C; Gluckman E; Passweg J; Ruggeri A
Biol Blood Marrow Transplant; 2017 Nov; 23(11):1939-1948. PubMed ID: 28797779
[TBL] [Abstract][Full Text] [Related]
18. Successful reduced-intensity conditioning hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria with aplastic anemia in two children.
Andolina JR; Reinish AL; Akhtar R; Noronha S; Shand JC; Girvin A; Korones DN; Bruckner LB; Mullen CA; Curran KJ; Boulad F
Pediatr Blood Cancer; 2018 Aug; 65(8):e27218. PubMed ID: 29722478
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab.
Cooper JP; Farah RJ; Stevenson PA; Gooley TA; Storb R; Scott BL
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1331-1339. PubMed ID: 30711779
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic Hematopoietic Stem Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria: Multicenter Analysis by the Polish Adult Leukemia Group.
Markiewicz M; Drozd-Sokolowska J; Biecek P; Dzierzak-Mietla M; Boguradzki P; Staniak M; Piatkowska-Jakubas B; Piekarska A; Tormanowska M; Halaburda K; Ussowicz M; Waszczuk-Gajda A; Basak G; Bołkun L; Rybka J; Sadus-Wojciechowska M; Giebel S; Szmigielska-Kaplon A; Mendek-Czajkowska E; Warzybok K; Burdacki A; Dwilewicz-Trojaczek J
Biol Blood Marrow Transplant; 2020 Oct; 26(10):1833-1839. PubMed ID: 32512214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
